Atlas Trials

Efficacy and Tolerance of Liraglutide for Weight Loss in Obese Type 2 Diabetic Hemodialysis Patients

Clinical trial NCT04529278 · UNKNOWN

Trial details

NCT number
NCT04529278
Sponsor
Fondation Hôpital Saint-Joseph
Status
UNKNOWN
Phase
Phase 2
Study type
INTERVENTIONAL
Diabetes Mellitus, Type 2HemodialysisObese
Start date
2021-01-18
Primary completion
2023-01-17
Enrollment
18

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.